Evaluation of diastolic dysfunction in multi-transfused thalassemia patients

Authors

  • Mitsu P. Vithalani Department of Pediatrics, M. P. Shah Government Medical College, Jamnagar, Gujarat, India
  • Bhadresh R. Vyas Department of Pediatrics, M. P. Shah Government Medical College, Jamnagar, Gujarat, India
  • Namrata Makvana Department of Pediatrics, M. P. Shah Government Medical College, Jamnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20231145

Keywords:

Thalassemia, Diastolic dysfunction, Echocardiography

Abstract

Background: An important complication of thalassemia is iron deposition in the cardiac tissue resulting in degeneration, fibrosis and dysfunction. Cardiac disease is the primary cause of death. Aims and objectives were to detect early cardiac involvement in patients with transfusion dependent thalassemia by conventional doppler echocardiography and tissue doppler imaging while they are still asymptomatic.

Methods: 150 patients in the age group of 2-18 years who were receiving regular and frequent blood transfusions were enrolled in this study. Institutional ethical clearance was taken. After informed consent, 2D echocardiography was performed on all the patients. Previous blood reports reviewed. Various parameters like mitral flow pattern, LVEF and Tricuspid regurgitant jets were taken into account to diagnose cardiac dysfunction. Results analysed by standard statistical tests.

Results: Out of 150 patients, 58% were males and 42% were female patients. The 13 (8.6%) patients were diagnosed as having diastolic dysfunction. Out of 150, majority (86.6%) were below the age of 15 years, 81.33% children were diagnosed as having thalassemia before the age of 2 years, 97% patients were on regular iron chelation therapy, 32% patients had pre-transfusion Hb <7 gm/dl, 78.66% patients had S. ferritin levels >2500 ng/ml and more number of males (7.33%) have undergone splenectomy than females.

Conclusions: Diastolic dysfunction on Doppler echocardiography is an early sign of myocardial dysfunction in patients with beta thalassemia.

 

 

References

National Health Mission (NHM). Prevention and control of hemoglobinopathies in India- Thalassemia, Sickle cell disease and other variant hemoglobins. Guidelines on Hemoglobinopathies in India, 2016.

Ozment CP, Turi JL. Iron overload following red blood cell transfusion and it’s impact on disease severity. Biochim. Biophys. Acta. 2009;1790:694-701.

Mohan JC, Reddy KS. Thalassemic cardiopathy: Current concepts. Indian J Pediatr. 1984;51:383-6.

Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167-84.

Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J et al. Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. Circulation. 2009;120:1961-8.

Kremastinos DT, Tsiapras DP, Tsetsos GA. Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation. 1993;88:1127-35.

Chinprateep B, Ratanasit N, Kaolawanich Y, Karaketklang K, Saiviroonporn P, Viprakasit V et al. Prevalence of left ventricular diastolic dysfunction by cardiac magnetic resonance imaging in thalassemia major patients with normal left ventricular systolic function. BMC Cardiovascular Disorders. 2019;19:245.

Sambhaji CC. Cardiac abnormalities in patients with beta thalassemia. Int J Contemporary Pediatr. 2016;3(1);224-8.

Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-31.

Sayed SZ, Aly BA, El-Hakim A, Omar SM, Amin AS. The early cardiac involvement in patients with B-thalassemia major. Egypt Heart J. 2013;65:243-9.

Caro JJ, Ward A, Green TC, Huybrechts K, Arana A, Wait S et al. Impact of thalassemia major on patients and their families. Acta Haematologica. 2002;107:150-7.

Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J et al. Cardiac status in well-treated patients with thalassemia major. Eur J Haematol. 2004;73:359-66.

Bosi G, Crepaz M, Gamberini R, Fortini M, Scarcia S, Bonsante E et al. Left ventricular remodelling, and systolic and diastolic function in young adults with beta-thalassemia major: a Doppler echocardiographic assessment and correlation with haematological data. Heart. 2003;89:762-6.

Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A et al. Survival in medically treated patients with homozygous beta thalassemia. N Engl J Med. 1994;331:574-8.

Downloads

Published

2023-04-27

Issue

Section

Original Research Articles